COVID-19 pandemic
Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19 and not simply prevent symptomatic infections.
Sources: U.S. News & World Report via MSN
Changes
- Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19, and not simply prevent symptomatic infections.
- Preliminary tests indicate that the Oxford–AstraZeneca COVID-19 vaccine may reduce transmission of COVID-19 and not simply prevent symptomatic infections.
Related
Chancellor Angela Merkel receives her first dose of the Oxford–AstraZeneca vaccine.
Toronto Mayor John Tory receives his first dose of the AstraZeneca vaccine.
Saudi Arabia's Food and Drug Authority approves the use of the Oxford–AstraZeneca vaccine.